Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Capital Expenditures (2018 - 2025)

Evolus' Capital Expenditures history spans 8 years, with the latest figure at -$883000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 301.6% year-over-year to -$883000.0; the TTM value through Dec 2025 reached $3.4 million, up 133.76%, while the annual FY2025 figure was $3.4 million, 133.76% up from the prior year.
  • Capital Expenditures reached -$883000.0 in Q4 2025 per EOLS's latest filing, down from $3.3 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $3.3 million in Q3 2025 to a low of -$883000.0 in Q4 2025.
  • Average Capital Expenditures over 5 years is $355000.0, with a median of $329500.0 recorded in 2022.
  • Peak YoY movement for Capital Expenditures: surged 2266.67% in 2023, then plummeted 301.6% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $393000.0 in 2021, then surged by 44.78% to $569000.0 in 2022, then crashed by 192.97% to -$529000.0 in 2023, then soared by 182.8% to $438000.0 in 2024, then tumbled by 301.6% to -$883000.0 in 2025.
  • Per Business Quant, the three most recent readings for EOLS's Capital Expenditures are -$883000.0 (Q4 2025), $3.3 million (Q3 2025), and -$535000.0 (Q2 2025).